A detailed history of Roxbury Financial LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Roxbury Financial LLC holds 237 shares of ADMA stock, worth $3,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares
237
Previous 237 -0.0%
Holding current value
$3,623
Previous $4.32 Million 19.51%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025

BUY
$17.6 - $24.51 $4,171 - $5,808
237 New
237 $4.32 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Roxbury Financial LLC Portfolio

Follow Roxbury Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roxbury Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roxbury Financial LLC with notifications on news.